Position in NVS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,142,488
+$28,635 QoQ
Shares Held
7,290
-0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#580
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILTON CAPITAL MANAGEMENT LLC holds $189,707,778 across 12 Drug Manufacturers - General names. NVS ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
69,286 | $83,103,713 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
411,727 | $52,017,589 | |
| 3 | AZN |
Astrazeneca PLC
|
201,189 | $38,149,458 | |
| 4 | JNJ |
Johnson & Johnson
|
21,048 | $5,345,560 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,329 | $3,768,776 | |
| 6 | ABBV |
AbbVie Inc.
|
13,608 | $3,424,317 | |
| 7 | AMGN |
Amgen Inc
|
4,095 | $1,482,881 | |
| 8 | NVS |
Novartis AG
This page
|
7,290 | $1,142,488 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,142,488 | 7,290 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,113,853 | 7,292 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,087,656 | 7,889 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,105,428 | 8,620 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,189,528 | 9,830 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,103,874 | 9,902 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,001,027 | 10,287 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,230,714 | 10,700 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,146,574 | 10,770 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,101,561 | 11,388 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,078,359 | 10,680 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $1,088,883 | 10,690 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,084,076 | 10,743 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $991,300 | 10,775 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $1,060,698 | 11,692 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $874,191 | 11,501 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $873,533 | 10,334 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $914,881 | 10,426 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $713,842 | 8,161 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $700,936 | 8,571 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $631,563 | 6,922 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $12,179,703 | 142,486 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $14,245,143 | 150,854 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $13,130,786 | 150,998 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $12,297,297 | 140,798 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $11,146,085 | 135,186 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||